US shrinkflation 2026 at Walmart and Target: American shoppers are facing a hidden price hike as companies shrink product ...

Jeffrey Hirsch called Dow 38,820 by 2025 back in 2010, when the index was trading around 10,000. That target has already been ...

Over the weekend, the DECC hosted the state bullseye archery tournament. 92 teams and more than 2,200 kids from throughout Minnesota, ranging from elementary to high school, competed for a chance to ...

The global financial spotlight has shifted back to the digital gold rush as Bitcoin price action retests the $66,000 mark. This surge is not just about the king of crypto; it is a massive signal that ...

None of this was new information, and all of it had previously been reported by various local, state and national news outlets over the past few years. But the opinion piece added sharp new language ...

The district's first through fifth grades wrapped up swim safety lessons this week at the Paine Aquatic Center. "Meredith and Natalie spent a great deal of time planning out the curriculum to meet the ...

Target Circle Deal Days ends tonight, so you have limited time to take advantage of exclusive discounts on bestselling products across beauty, appliances and more for Target Circle and Target Circle ...

The Associated Press reported on Wednesday that Iran has received a 15-point plan from the U.S. to end the war. Trump suggested in the Oval Office that Tehran is eager to make a peace deal, even as ...

Joanne Stocker is a verification producer for CBS News Confirmed. She was previously chief editor of Kurdistan 24 English and managing editor at The Defense Post. She has combined open-source ...

Nasdaq is wiring its collateral and surveillance systems into Talos’s institutional trading stack to target a $35 billion “trapped” collateral problem. Nasdaq will integrate its Calypso risk and ...

CLL17 finds fixed-duration venetoclax regimens match continuous ibrutinib at 3 years, boosting confidence in personalized frontline CLL choices. Results from the phase 3 CLL17 trial (NCT04608318) are ...